Everest Medicines Announces New Drug Application Acceptance by the Pharmaceutical Administration Bureau of Macao for Nefecon® for the Treatment of Primary IgA Nephropathy
SHANGHAI, Aug. 25, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today...
YS Biopharma Announces Purchase of Shares by Company Officers
GAITHERSBURG, Md., Aug. 25, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of...
Khadas Introduces Mind Series to Deliver a Next-Gen Portable Computing Experience with an Innovative Ecosystem
Khadas Mind is now available to order via a Kickstarter crowdfunding campaign. SHENZHEN, China, Aug. 24, 2023 /PRNewswire/ -- Khadas, an emerging technology company that designs and manufactures cutting-edge computing and electronic devices, today...
TD Holdings, Inc. Enters into a US$165 Million Procurement Agency Agreement
To march into the renewable energy sector, and create new curve for business performance SHENZHEN, China, Aug. 24, 2023 /PRNewswire/ -- TD Holdings, Inc. (Nasdaq: GLG) (the "Company"), a commodities trading service provider in China today announced...
Youdao Reports Second Quarter 2023 Unaudited Financial Results
HANGZHOU, China, Aug. 24, 2023 /PRNewswire/ -- Youdao, Inc. ("Youdao" or the "Company") (NYSE: DAO), an intelligent learning company with industry-leading technology in China, today announced its unaudited financial results for the second quarter...
Computer vision software developer VisualCortex to exhibit at ASIAL 2023 with Axis Communications
Video analytics platform vendor, VisualCortex, joins Axis Communications at ASIAL's Security Exhibition & Conference 2023 to showcase its people and vehicle computer vision solutions SYDNEY, Aug. 24, 2023 /PRNewswire/ -- VisualCortex – the Video...
Everest Medicines Announces Interim Results for First Half of 2023
SHANGHAI, Aug. 24, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced...
VNG Files Registration Statement for Potential Initial Public Offering
NOT FOR DISTRIBUTION IN OR INTO OR FROM THE UNITED STATES OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION HO CHI MINH CITY, Vietnam, Aug. 24, 2023 /PRNewswire/ -- VNG Corporation ("VNG"...